Pasar al contenido principal

EVOLUCION COMPUTACIONAL DE ENZIMAS MEDIANTE LA EXPLORACION DE LA SUPERFICIE CONFORMACIONAL

PGC2018-102192-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT DE GIRONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 21
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

  • Codony, Sandra|||0000-0003-0539-673X
  • Pont, Caterina|||0000-0001-9118-0892
  • Griñán-Ferré, Christian|||0000-0002-5424-9130
  • Di Pede-Mattatelli, Ania
  • Calvó-Tusell, Carla|||0000-0003-2681-8460
  • Feixas, Ferran|||0000-0001-5147-0000
  • Osuna, Sílvia|||0000-0003-3657-6469
  • Jarné-Ferrer, Júlia
  • Naldi, Marina
  • Bartolini, Manuela|||0000-0002-2890-3856
  • Loza, María Isabel|||0000-0003-4730-0863
  • Brea, José|||0000-0002-5523-1979
  • Pérez, Belén|||0000-0001-5801-1704
  • Bartra, Clara
  • Sanfeliu i Pujol, Coral|||0000-0002-9004-1206
  • Juárez-Jiménez, Jordi|||0000-0003-1464-1397
  • Morisseau, Christophe
  • Hammock, Bruce D.|||0000-0003-1408-8317
  • Pallàs, Mercè|||0000-0003-3095-4254
  • Vázquez, Santiago|||0000-0002-9296-6026
  • Muñoz-Torrero López-Ibarra, Diego|||0000-0002-8140-8555
With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer's disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chlorotacrine (huprine)-TPPU hybrids as dual inhibitors of the enzymes soluble epoxide hydrolase (sEH) and acetylcholinesterase (AChE), a multitarget profile to provide cumulative effects against neuroinflammation and memory impairment. Computational studies confirmed the gorge-wide occupancy of both enzymes, from the main site to a secondary site, including a so far non-described AChE cryptic pocket. The lead compound displayed in vitro dual nanomolar potencies, adequate brain permeability, aqueous solubility, human microsomal stability, lack of neurotoxicity, and it rescued memory, synaptic plasticity, and neuroinflammation in an AD mouse model, after low dose chronic oral administration.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Discovery and in vivo proof of concept of a highly potent dual inhibitor of soluble Epoxide Hydrolase and Acetylcholinesterase for the treatment of Alzheimer’s disease

  • Codony, Sandra
  • Pont, Caterina
  • Griñán Ferré, Christian
  • Pede-Mattatelli, Ania di
  • Calvó Tusell, Carla
  • Feixas, Ferrán
  • Osuna, Sílvia
  • Jarné Ferrer, Júlia
  • Naldi, Marina
  • Bartolini, Manuela
  • Loza García, María Isabel
  • Brea Floriani, José Manuel
  • Pérez, Belén
  • Bartra, Clara
  • Sanfeliu, Coral
  • Juárez Jiménez, Jordi
  • Morisseau, Christophe
  • Hammock, Bruce D.
  • Pallàs, Mercè
  • Vázquez, Santiago
  • Muñoz Torrero, Diego
With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer’s disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chlorotacrine (huprine)–TPPU hybrids as dual inhibitors of the enzymes soluble epoxide hydrolase (sEH) and acetylcholinesterase (AChE), a multitarget profile to provide cumulative effects against neuroinflammation and memory impairment. Computational studies confirmed the gorge-wide occupancy of both enzymes, from the main site to a secondary site, including a so far non-described AChE cryptic pocket. The lead compound displayed in vitro dual nanomolar potencies, adequate brain permeability, aqueous solubility, human microsomal stability, lack of neurotoxicity, and it rescued memory, synaptic plasticity, and neuroinflammation in an AD mouse model, after low dose chronic oral administration
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis

  • Codony, Sandra
  • Calvó-Tusell, Carla
  • Valverde, Elena
  • Osuna, Sílvia
  • Morisseau, Christophe
  • Loza García, María Isabel
  • Brea Floriani, José Manuel
  • Pérez, Concepción
  • Rodríguez-Franco, María Isabel
  • Pizarro-Delgado, Javier
  • Corpas, Rubén
  • Griñán-Ferré, Christian
  • Pallàs, Mercè
  • Sanfeliu, Coral
  • Vázquez-Carrera, Manuel
  • Hammock, Bruce D.
  • Feixas, Ferran
  • Vázquez, Santiago
The pharmacological inhibition of soluble epoxide hydrolase (sEH) is efficient for the treatment of inflammatory and pain-related diseases. Numerous potent sEH inhibitors (sEHIs) present adamantyl or phenyl moieties, such as the clinical candidates AR9281 or EC5026. Herein, in a new series of sEHIs, these hydrophobic moieties have been merged in a benzohomoadamantane scaffold. Most of the new sEHIs have excellent inhibitory activities against sEH. Molecular dynamics simulations suggested that the addition of an aromatic ring into the adamantane scaffold produced conformational rearrangements in the enzyme to stabilize the aromatic ring of the benzohomoadamantane core. A screening cascade permitted us to select a candidate for an in vivo efficacy study in a murine model of cerulein-induced acute pancreatitis. The administration of 22 improved the health status of the animals and reduced pancreatic damage, demonstrating that the benzohomoadamantane unit is a promising scaffold for the design of novel sEHIs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis

  • Codony, Sandra
  • Pujol, Eugènia
  • Pizarro, J.
  • Feixas, Ferran
  • Valverde,E.
  • Loza, María Isabel
  • Brea, José Manuel
  • Saez, Elena
  • Oyarzabal, Julen
  • Pineda-Lucena, Antonio
  • Pérez, Belén
  • Pérez, Concepción
  • Rodríguez-Franco, María Isabel
  • Leiva, Rosana
  • Osuna, Sílvia
  • Morissea, Christophe
  • Hammock, Bruce D.
  • Vázquez-Carrera, Manuel
  • Vázquez, Santiago
In vivo pharmacological inhibition of soluble epoxide hydrolase (sEH) reduces inflammatory diseases, including acute pancreatitis (AP). Adamantyl ureas are very potent sEH inhibitors, but the lipophilicity and metabolism of the adamantane group compromise their overall usefulness. Herein, we report that the replacement of a methylene unit of the adamantane group by an oxygen atom increases the solubility, permeability, and stability of three series of urea-based sEH inhibitors. Most of these oxa-analogues are nanomolar inhibitors of both the human and murine sEH. Molecular dynamics simulations rationalize the molecular basis for their activity and suggest that the presence of the oxygen atom on the adamantane scaffold results in active site rearrangements to establish a weak hydrogen bond. The 2-oxaadamantane 22, which has a good solubility, microsomal stability, and selectivity for sEH, was selected for further in vitro and in vivo studies in models of cerulein-induced AP. Both in prophylactic and treatment studies, 22 diminished the overexpression of inflammatory and endoplasmic reticulum stress markers induced by cerulein and reduced the pancreatic damage., This work was funded by the Spanish Ministerio de Economía Industria y Competitividad (grants SAF2017-82771-R to S.V., SAF2015-64146-R, andMICIU/ICTI2017-2020/Referencito M.V.-C., RTI2018-093955-B-C21 to M.I.R.-F., PGC2018-102192-B-I00 to S.O. and RTI2018-101032-J-I00 to F.F.), the CaixaImpulse 2015 Programme, the Spain EIT Health (Proof of concept 2016), the European Regional Development Fund (ERDF),the Xunta de Galicia (GRC2014/011 and ED431C2018-21), the Fundació Bosch i Gimpera, Universitat de Barcelona (F2I grant), the Generalitat de Catalunya (2017 SGR 106, 2017 SGR 124 and 2017 SGR 1707), the Fundacion Fuentes Dutor ́ , the European Research Council (ERC-2015- StG-679001- NetMoDEzyme to S.O.), and the European Community (MSCA-IF-2014-EF-661160-MetAccembly to F.F.). S.C. and E.P. acknowledge PhD fellowships from the Universitat de Barcelona (APIF grants). E.V. and R.L. thank the Institute of Biomedicine of the University of Barcelona (IBUB) and the Spanish Ministerio de Educacion, Cultura y Deporte ́ (FPU grant), respectively, for PhD grants. Partial support was provided by NIH-NIEHS River Award R35 ES03443, NIHNIEHS Superfund Program P42 ES004699, NINDS R01 DK107767, and NIDDK R01 DK103616. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Daniel Closa (IIBB−CSIC, Barcelona, Spain) for advice regarding the histological analyses.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Insights into the molecular determinants of thermal stability in halohydrin dehalogenase HheD2

  • Wessel, Julia
  • Petrillo, Giovanna
  • Estevez-Gay, Miquel
  • Bosch, Sandra
  • Seeger, Margarita
  • Dijkman, Willem P.
  • Iglesias-Fernández, Javier
  • Hidalgo, Aurelio
  • Usón, Isabel
  • Osuna, Sílvia
  • Schallmey, Anett
© 2021 The Authors., Halohydrin dehalogenases (HHDHs) are promising enzymes for application in biocatalysis due to their promiscuous epoxide ring-opening activity with various anionic nucleophiles. So far, seven different HHDH subtypes A to G have been reported with subtype D containing the by far largest number of enzymes. Moreover, several characterized members of subtype D have been reported to display outstanding characteristics such as high catalytic activity, broad substrate spectra or remarkable thermal stability. Yet, no structure of a D-type HHDH has been reported to date that could be used to investigate and understand those features on a molecular level. We therefore solved the crystal structure of HheD2 from gamma proteobacterium HTCC2207 at 1.6 Å resolution and used it as a starting point for targeted mutagenesis in combination with molecular dynamics (MD) simulation, in order to study the low thermal stability of HheD2 in comparison with other members of subtype D. This revealed a hydrogen bond between conserved residues Q160 and D198 to be connected with a high catalytic activity of this enzyme. Moreover, a flexible surface region containing two α-helices was identified to impact thermal stability of HheD2. Exchange of this surface region by residues of HheD3 yielded a variant with 10 °C higher melting temperature and reaction temperature optimum. Overall, our results provide important insights into the structure–function relationship of HheD2 and presumably for other D-type HHDHs., This work has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 635595 (CARBAZYMES). This work was further supported by grants PGC2018-101370-B-100 (the Spanish Ministry of Science and Innovation and EU FEDER fonds) and the Generalitat de Catalunya (2017SGR-1192). We also thank the Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707) and Spanish MINECO for project PGC2018-102192-B-I00. JIF was supported by the European Community for Marie Curie fellowship (H2020-MSCA-IF-2016-753045) and Juan de la Cierva-Incorporación fellowship (IJCI-2017-34129). SO is grateful to the funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Program (ERC-2015-StG-679001).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis, in vitro profiling and in vivo evaluation of benzohomoadamantane-based ureas for visceral pain: a new indication for soluble epoxide hydrolase inhibitors

  • Codony, Sandra
  • Entrena, José M.
  • Calvó-Tusell, Carla
  • Osuna, Sílvia
  • Jora, Beatrice
  • González-Cano, Rafael
  • Corpas, Rubén
  • Morisseau, Christophe
  • Pérez, Belén
  • Barniol-Xicota, Marta
  • Griñán-Ferré, Christian
  • Pérez, Concepción
  • Rodríguez-Franco, María Isabel
  • Martínez, Antón L.
  • Loza, María Isabel
  • Pallàs, Mercè
  • Verhelst, Steven H. L.
  • Sanfeliu, Coral
  • Feixas, Ferran
  • Hammock, Bruce D.
  • Brea, José Manuel
  • Cobos, Enrique J.
  • Vázquez, Santiago
The soluble epoxide hydrolase (sEH) has been suggested as a pharmacological target for the treatment of several diseases, including pain-related disorders. Herein, we report further medicinal chemistry around new benzohomoadamantane-based sEH inhibitors (sEHI) in order to improve the drug metabolism and pharmacokinetics properties of a previous hit. After an extensive in vitro screening cascade, molecular modeling, and in vivo pharmacokinetics studies, two candidates were evaluated in vivo in a murine model of capsaicin-induced allodynia. The two compounds showed an anti-allodynic effect in a dose-dependent manner. Moreover, the most potent compound presented robust analgesic efficacy in the cyclophosphamide-induced murine model of cystitis, a well-established model of visceral pain. Overall, these results suggest painful bladder syndrome as a new possible indication for sEHI, opening a new range of applications for them in the visceral pain field., This work was funded by the Spanish Ministerio de Economía, Industria y Competitividad (grants SAF2017-82771-R to S.V., RTI2018-093955-B-C21 to M.I.R.-F., PGC2018-102192-B-I00 to S.O. and RTI2018-101032-J-I00 to F.F.), the Spanish MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” (Grant PID2020-118127RB-I00 to S.V. and Grant PID2019-106285RB to M.P. and C.S.) funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, the Xunta de Galicia (ED431G 2019/02 and ED431C 2018/21), the Fundació Bosch i Gimpera, Universitat de Barcelona (F2I grant), the Generalitat de Catalunya (2017 SGR 106 and 2017 SGR 1707), the European Research Council (ERC-2015-StG-679001-NetMoDEzyme to S.O.), and the European Community (MSCA-IF-2014-EF661160-MetAccembly to F.F.). S.C. acknowledges a PhD fellowship from the Universitat de Barcelona (APIF grant) and the Spanish Society of Medicinal Chemistry (SEQT) and Lilly for an “Award for Novel Researchers in the Discovery and Development of New Drugs”. M.B.X. acknowledges FWO for a post-doctoral fellowship (no. 12Y0720N). S.H.L.V. acknowledges the Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen, the Regierende Bürgermeister von Berlin, and the Bundesministerium für Bildung und Forschung. F.F. acknowledges Spanish MICINN for a Ramón y Cajal fellowship (RYC2020-029552-I). Partial support was provided by NIH-NIEHS River Award R35 ES03443, NIH-NIEHS Superfund Program P42 ES004699, NINDS R01 DK107767, and NIDDK R01 DK103616 to B.D.H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

  • Codony, Sandra
  • Pont, Caterina
  • Griñán-Ferré, Christian
  • Di Pede-Mattatelli, Ania
  • Calvó-Tusell, Carla
  • Feixas, Ferran
  • Osuna, Sílvia
  • Jarné-Ferrer, Júlia
  • Naldi, Marina
  • Bartolini, Manuela
  • Loza, María Isabel
  • Brea, José Manuel
  • Pérez, Belén
  • Bartra Cabré, Clara
  • Sanfeliu, Coral
  • Juárez-Jiménez, Jordi
  • Morisseau, Christophe
  • Hammock, Bruce D.
  • Pallàs, Mercè
  • Vázquez, Santiago
  • Muñoz-Torrero, Diego
With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer's disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chlorotacrine (huprine)-TPPU hybrids as dual inhibitors of the enzymes soluble epoxide hydrolase (sEH) and acetylcholinesterase (AChE), a multitarget profile to provide cumulative effects against neuroinflammation and memory impairment. Computational studies confirmed the gorge-wide occupancy of both enzymes, from the main site to a secondary site, including a so far non-described AChE cryptic pocket. The lead compound displayed in vitro dual nanomolar potencies, adequate brain permeability, aqueous solubility, human microsomal stability, lack of neurotoxicity, and it rescued memory, synaptic plasticity, and neuroinflammation in an AD mouse model, after low dose chronic oral administration., This work was supported by grants PID2020-118127RB-I00, SAF2017-82771-R, PID2020-115683GA-I00, PGC2018- 102192-B-I00, PID2019-106285RB, and RTI2018-101032-JI00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, ED431C 2018/21 and ED431G 2019/02 from Xunta de Galicia, and 2017SGR106, 2017SGR1707, and 2019LLAV00017 from AGAUR. Partial support was provided by NIH-NIEHS River Award R35 ES03443, NIH-NIEHS Superfund Program P42 ES004699, NINDS R01 DK107767, and NIDDK R01 DK103616 to B.D.H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Fellowships from Ministerio de Educación, Cultura y Deporte to C.P. (FPU15/01131), from the University of Barcelona to S.C., and a starting grant from the European Research Council (ERC-2015-StG-679001- NetMoDEzyme) to S.O. are gratefully acknowledged. We thank Ms. Cecilia Mariani for technical assistance in the assays with mAChE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis

  • Codony, Sandra
  • Calvó-Tusell, Carla
  • Valverde, Elena
  • Osuna, Sílvia
  • Morisseau, Christophe
  • Loza, M. Isabel
  • Brea, José
  • Pérez, Concepción
  • Rodríguez-Franco, María Isabel
  • Pizarro-Delgado, Javier
  • Corpas, Rubén
  • Griñán-Ferré, Christian
  • Pallàs, Mercè
  • Sanfeliu, Coral
  • Vázquez-Carrera, Manuel
  • Hammock, Bruce D.
  • Feixas, Ferran
  • Vázquez, Santiago
The pharmacological inhibition of soluble epoxide hydrolase (sEH) is efficient for the treatment of inflammatory and pain-related diseases. Numerous potent sEH inhibitors (sEHIs) present adamantyl or phenyl moieties, such as the clinical candidates AR9281 or EC5026. Herein, in a new series of sEHIs, these hydrophobic moieties have been merged in a benzohomoadamantane scaffold. Most of the new sEHIs have excellent inhibitory activities against sEH. Molecular dynamics simulations suggested that the addition of an aromatic ring into the adamantane scaffold produced conformational rearrangements in the enzyme to stabilize the aromatic ring of the benzohomoadamantane core. A screening cascade permitted us to select a candidate for an in vivo efficacy study in a murine model of cerulein-induced acute pancreatitis. The administration of 22 improved the health status of the animals and reduced pancreatic damage, demonstrating that the benzohomoadamantane unit is a promising scaffold for the design of novel sEHIs., This work was funded by the Spanish Ministerio de Economía, Industria y Competitividad (grants SAF2017-82771-R to S.V., RTI2018-093999-B-100 to M. V.-C., RTI2018-093955-B-C21 to M.I.R.-F., SAF2016-77703-C2 to M.P. and C.S., PGC2018- 102192-B-I00 to S.O. and RTI2018-101032-J-I00 to F.F.), the Spain EIT Health (Proof of concept 2016), the European Regional Development Fund (ERDF), the Xunta de Galicia (ED431G 2019/02 and ED431C 2018/21), the Fundació Bosch i Gimpera, Universitat de Barcelona (F2I grant), the Generalitat de Catalunya (2017 SGR 106, 2017 SGR 124 and 2017 SGR 1707), the European Research Council (ERC-2015-StG-679001-Net- MoDEzyme to S.O.), and the European Community (MSCA-IF- 2014-EF-661160-MetAccembly to F.F.). S.C. and E.V. acknowledge the PhD fellowships from the Universitat de Barcelona (APIF grant) and the Institute of Biomedicine of the University of Barcelona (IBUB), respectively. Partial support was provided by NIH-NIEHS River Award R35 ES03443, NIH-NIEHS Superfund Program P42 ES004699, NINDS R01 DK107767, and NIDDK R01 DK103616 to B.D.H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Enzyme Conformation Influences the Performance of Lipase-powered Nanomotors

  • Wang, Lei
  • Marciello, Marzia
  • Estévez Gay, Miquel
  • Soto Rodriguez, Paul E. D.
  • Luengo Morato, Yurena
  • Iglesias-Fernández, Javier
  • Huang, Xin
  • Osuna Oliveras, Sílvia
  • Filice, Marco
  • Sánchez, Samuel
Enzyme-powered micro/nanomotors have myriads of potential applications in various areas. To efficiently reach those applications, it is necessary and critical to understand the fundamental aspects affecting the motion dynamics. Herein, we explored the impact of enzyme orientation on the performance of lipase-powered nanomotors by tuning the lipase immobilization strategies. The influence of the lipase orientation and lid conformation on substrate binding and catalysis was analyzed using molecular dynamics simulations. Besides, the motion performance indicates that the hydrophobic binding (via OTES) represents the best orienting strategy, providing 48.4 % and 95.4 % increase in diffusion coefficient compared to hydrophilic binding (via APTES) and Brownian motion (no fuel), respectively (with C[triacetin] of 100 mm). This work provides vital evidence for the importance of immobilization strategy and corresponding enzyme orientation for the catalytic activity and in turn, the motion performance of nanomotors, and is thus helpful to future applications, L. W. thanks the NSFC (No. 51703043), the Marie Sklodowska-Curie Fellowship (Grant No. 712754), and the Severo Ochoa programme (Grant SEV-2014-0425(2015-2019)). X.H. appreciates the NSFC (No. 21871069). P.E.D.S.R acknowledges postdoctoral fellowship support from the Spanish MINECO “Juan de la Cierva formación” program 2016 FJCI-2016-29512. M.M, Y.L.M. and M.F. are grateful to the Comunidad Autonoma de Madrid and FEDER for the I+D collaborative Programme in Biomedicine NIETO-CM (Project reference B2017-BMD3731). S.O. thanks the Generalitat de Catalunya for the emerging group CompBioLab (No. 2017 SGR-1707), Spanish MINECO for project PGC2018-102192-B-I00, and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (No. ERC-2015-StG-679001). J.I.F. acknowledges postdoctoral fellowship support from the Spanish MINECO “Juan de la Cierva formación” program IJCI-2017-34129, and the Marie Sklodowska-Curie Fellowship (H2020-MSCA-IF-2016-753045, J.I.F). M.F. thanks MINECO for the research grant No. SAF2014-59118-JIN co-funded by FEDER and also the Comunidad Autonoma de Madrid for research project No. 2017-T1/BIO-4992 (“Atracción de Talento” Action) co-funded by Universidad Complutense de Madrid. The CNIC is supported by MINECO and the Pro-CNIC Foundation and is a Severo Ochoa Centre of Excellence (SEV-2015-0505). S.S. thanks the Spanish MINECO for grants CTQ2015-68879-R (MICRODIA) and CTQ2015-72741-EXP (Enzwim), and Proyecto RTI2018-098164-B-I00 funded by MCIU/AEI/FEDER, UE
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Pervasive cooperative mutational effects on multiple catalytic enzyme traits emerge via long-range conformational dynamics

  • Acevedo-Rocha, Carlos G.
  • Li, Aitao
  • D’Amore, Lorenzo
  • Hoebenreich, Sabrina
  • Sanchis, Joaquin
  • Lubrano, Paul
  • Ferla, Matteo P.
  • Garcia Borràs, Marc
  • Osuna Oliveras, Sílvia
  • Reetz, Manfred T.
Multidimensional fitness landscapes provide insights into the molecular basis of laboratory and natural evolution. To date, such efforts usually focus on limited protein families and a single enzyme trait, with little concern about the relationship between protein epistasis and conformational dynamics. Here, we report a multiparametric fitness landscape for a cytochrome P450 monooxygenase that was engineered for the regio- and stereoselective hydroxylation of a steroid. We develop a computational program to automatically quantify non-additive effects among all possible mutational pathways, finding pervasive cooperative signs and magnitude epistasis on multiple catalytic traits. By using quantum mechanics and molecular dynamics simulations, we show that these effects are modulated by long-range interactions in loops, helices and β-strands that gate the substrate access channel allowing for optimal catalysis. Our work highlights the importance of conformational dynamics on epistasis in an enzyme involved in secondary metabolism and offers insights for engineering P450s, Support from the Max-Planck-Society and the LOEWE Research cluster SynChemBio is gratefully acknowledged. A.L. thanks the support from the National Key Research and Development Program of China (2019YFA0905000). This study was also supported in part by the European Research Council Horizon 2020 research and innovation programme (ERC-2015-StG-679001, to S.O.), Spanish MINECO (project PGC2018-102192-B-I00, to S.O.; project PID2019-111300GA-I00, to M.G.-B.; and Juan de la Cierva - Incorporación fellowship IJCI-2017-33411, to M.G.-B.), UdG (predoctoral fellowship IFUdG2016, to L.D.), and Generalitat de Catalunya AGAUR (SGR-1707, to S.O.; and Beatriu de Pinós H2020 MSCA-Cofund 2018-BP-00204, to M.G.-B.). M.P.F. is supported by the Wellcome Trust [203141/Z/16/Z] and the NIHR Biomedical Research Centre Oxford
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mutational Analysis of Linalool Dehydratase Isomerase Suggests That Alcohol and Alkene Transformations Are Catalyzed Using Noncovalent Mechanisms

  • Cuetos, Anibal
  • Iglesias-Fernández, Javier
  • Danesh-Azari, Hamid-Reza
  • Zukic, Erna
  • Dowle, Adam
  • Osuna Oliveras, Sílvia
  • Grogan, Gideon
The interconversion of nonactivated alkenes and alcohols, catalyzed by (de)hydratases, has great potential in biotechnology for the generation of fine and bulk chemicals. LinD is a cofactor-independent enzyme that catalyzes the reversible (de)hydration of the tertiary alcohol (S)-linalool to the triene β-myrcene and also its isomerization to the primary alcohol geraniol. Structure-informed mutagenesis of LinD, followed by activity studies, confirmed essential roles for residues C171, C180, and H129 in water activation for the hydration of β-myrcene to linalool. However, no evidence of covalent thioterpene intermediates was found using either X-ray crystallography, mass spectrometry, or QM/MM nudged elastic band simulations. Labeling and NMR experiments confirmed a role for residue D39 in (de)protonation of the linalool carbon C10 in the isomerization of linalool to geraniol and also the intermediacy of β-myrcene in this isomerization reaction. X-ray, molecular dynamics, and activity studies also suggested a significant role in catalysis for a mobile methionine residue M125, which exists in substantially altered orientations in different mutant structures, A.C. was funded by grant BB/P005578/1 from the BBSRC. We thank Dr Johan P. Turkenburg and Mr Sam Hart for assistance with X-ray data collection and the Diamond Light Source for access to beamlines I02, I03 and I04-1 under proposal number mx-9948. The York Centre of Excellence in Mass Spectrometry was created thanks to a major capital investment through Science City York, supported by Yorkshire Forward with funds from the Northern Way Initiative, and subsequent support from EPSRC (EP/K039660/1; EP/M028127/1). This study was also supported in part by the European Research Council Horizon 2020 research and innovation program (ERC-2015- StG-679001, S.O.), Spanish MINECO (project PGC2018-102192-B-I00, S.O.), Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707); Juan de la Cierva-Incorporación fellowship IJCI2017-34129, J. I.F), and Marie Curie EnzVolNet fellowship (H2020-MSCA-IF-2016-753045, J. I. F)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

C–H Bonds as Functional Groups: Simultaneous Generation of Multiple Stereocenters by Enantioselective Hydroxylation at Unactivated Tertiary C–H Bonds

  • Palone, Andrea
  • Casadevall Franco, Guillem
  • Ruiz-Barragán, Sergi
  • Call Quintana, Arnau
  • Osuna Oliveras, Sílvia
  • Bietti, Massimo
  • Costas Salgueiro, Miquel
Enantioselective C–H oxidation is a standing chemical challenge foreseen as a powerful tool to transform readily available organic molecules into precious oxygenated building blocks. Here, we describe a catalytic enantioselective hydroxylation of tertiary C–H bonds in cyclohexane scaffolds with H2O2, an evolved manganese catalyst that provides structural complementary to the substrate similarly to the lock-and-key recognition operating in enzymatic active sites. Theoretical calculations unveil that enantioselectivity is governed by the precise fitting of the substrate scaffold into the catalytic site, through a network of complementary weak non-covalent interactions. Stereoretentive C(sp3)–H hydroxylation results in a single-step generation of multiple stereogenic centers (up to 4) that can be orthogonally manipulated by conventional methods providing rapid access, from a single precursor to a variety of chiral scaffolds, The authors are thankful for the financial support by the European Research Council (AdvG883922 to M.C., 2015StG-679001and ERC-2022-POC-101112805 to S.O. and G.C., and ERC-2022-COG-101088032 to S.O.), Human Frontier Science Program (HFSP) under Grant RGP0054/2020 (S.O. and S.R.-B.), Spain, Ministry of Science, (MINECO,PRE2019-090149 to A.P., IJC2020-046115-I to A.C., PGC2018-102192-B-I00 to S.O., PGC2018-101737-BI00 to M.C.), and Generalitat de Catalunya (ICREA Academia to M.C., 2017SGR-00264 and 2017SGR-1707, Open Access funding provided thanks to the CRUE-CSIC agreement with American Chemical Society (ACS)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Conformational Landscapes of Halohydrin Dehalogenases and Their Accessible Active Site Tunnels

  • Estévez Gay, Miquel
  • Iglesias-Fernández, Javier
  • Osuna Oliveras, Sílvia
Halohydrin dehalogenases (HHDH) are industrially relevant biocatalysts exhibiting a promiscuous epoxide-ring opening reactivity in the presence of small nucleophiles, thus giving access to novel carbon–carbon, carbon–oxygen, carbon–nitrogen, and carbon–sulfur bonds. Recently, the repertoire of HHDH has been expanded, providing access to some novel HHDH subclasses exhibiting a broader epoxide substrate scope. In this work, we develop a computational approach based on the application of linear and non-linear dimensionality reduction techniques to long time-scale Molecular Dynamics (MD) simulations to study the HHDH conformational landscapes. We couple the analysis of the conformational landscapes to CAVER calculations to assess their impact on the active site tunnels and potential ability towards bulky epoxide ring opening reaction. Our study indicates that the analyzed HHDHs subclasses share a common breathing motion of the halide binding pocket, but present large deviations in the loops adjacent to the active site pocket and N-terminal regions. Such conformational differences affect the available tunnels for epoxide binding to the active site. The superior activity of the HHDH G subclass towards bulkier substrates is explained by the additional structural elements delimiting the active site region, its rich conformational heterogeneity, and the substantially wider and frequently observed active site tunnels. This study therefore provides key information for HHDH promiscuity and engineering, We thank the Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707) and Spanish MINECO for project PGC2018-102192-B-I00. J.I.F. was supported by the European Community for Marie Curie fellowship (H2020-MSCA-IF-2016-753045) and Juan de la Cierva-Incorporación fellowship (IJCI-2017-34129). S.O. is grateful to the funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC-2015-StG-679001)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Insights into the molecular determinants of thermal stability in halohydrin dehalogenase HheD2

  • Wessel, Julia
  • Petrillo, Giovanna
  • Estévez Gay, Miquel
  • Bosch, Sandra
  • Seeger, Margarita
  • Dijkman, Willem P.
  • Iglesias-Fernández, Javier
  • Hidalgo, Aurelio
  • Uson, Isabel
  • Osuna Oliveras, Sílvia
  • Schallmey, Anett
Halohydrin dehalogenases (HHDHs) are promising enzymes for application in biocatalysis due to their promiscuous epoxide ring opening activity with various anionic nucleophiles. So far, 7 different HHDH subtypes A to G have been reported with subtype D containing the by far largest number of enzymes. Moreover, several characterized members of subtype D have been reported to display outstanding characteristics such as high catalytic activity, broad substrate spectra or remarkable thermal stability. Yet, no structure of a D‐type halohydrin dehalogenase has been reported to date that could be used to investigate and understand those features on a molecular level. We therefore solved the crystal structure of HheD2 from gamma proteobacterium HTCC2207 at 1.6 Å resolution, and used it as a starting point for targeted mutagenesis in combination with molecular dynamics (MD) simulation, in order to study the low thermal stability of HheD2 in comparison to other members of subtype D. This revealed a hydrogen bond between conserved residues Q160 and D198 to be connected with a high catalytic activity of this enzyme. Moreover, a flexible surface region containing two α‐helices was identified to impact thermal stability of HheD2. Exchange of this surface region by residues of HheD3 yielded a variant with 10 °C higher melting temperature as well as reaction temperature optimum. Overall, our results provide important insights into the structure‐function relationship of HheD2 and presumably for other D‐type halohydrin dehalogenases, This work has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 635595 (CARBAZYMES). This work was further supported by grants PGC2018-101370-B-100 (the Spanish Ministry of Science and Innovation and EU FEDER fonds) and the Generalitat de Catalunya (2017SGR-1192). We also thank the Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707) and Spanish MINECO for project PGC2018-102192-BI00. J.I.F. was supported by the European Community for Marie Curie fellowship (H2020-MSCA-IF-2016- 753045) and Juan de la Cierva-Incorporación fellowship (IJCI-2017-34129). S.O. is grateful to the funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC-2015-StG-679001)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In Silico Identification and Experimental Validation of Distal Activity-Enhancing Mutations in Tryptophan Synthase

  • Maria Solano, Miguel A.
  • Kinateder, Thomas
  • Iglesias-Fernández, Javier
  • Sterner, Reinhard
  • Osuna Oliveras, Sílvia
Allostery is a central mechanism for the regulation of multi-enzyme complexes. The mechanistic basis that drives allosteric regulation is poorly understood but harbors key information for enzyme engineering. In the present study, we focus on the tryptophan synthase complex that is composed of TrpA and TrpB subunits, which allosterically activate each other. Specifically, we develop a rational approach for identifying key amino acid residues of TrpB distal from the active site. Those residues are predicted to be crucial for shifting the inefficient conformational ensemble of the isolated TrpB to a productive ensemble through intra-subunit allosteric effects. The experimental validation of the conformationally driven TrpB design demonstrates its superior stand-alone activity in the absence of TrpA, comparable to those enhancements obtained after multiple rounds of experimental laboratory evolution. Our work evidences that the current challenge of distal active site prediction for enhanced function in computational enzyme design has become within reach, We thank the Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707) and Spanish MINECO for project PGC2018-102192-B-I00. M.A.M.S. was supported by the Spanish MINECO for a PhD fellowship (BES-2015- 074964) and the National Research Foundation of Korea (NRF) under the Brain Pool Program (NRF2021H1D3A2A02038434), J. I. F. was supported by the European Community for Marie Curie fellowship (H2020- MSCA-IF-2016-753045) and Juan de la Cierva-Incorporación fellowship (IJCI-2017-34129). S.O. is grateful to the funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC-2015-StG-679001) and the Human Frontier Science Program (HFSP) for project grant RGP0054/2020
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Time Evolution of the Millisecond Allosteric Activation of Imidazole Glycerol Phosphate Synthase

  • Calvó-Tusell, Carla
  • Maria-Solano, Miguel A.
  • Osuna Oliveras, Sílvia
  • Feixas Geronès, Ferran
Deciphering the molecular mechanisms of enzymatic allosteric regulation requires the structural characterization of functional states and also their time evolution toward the formation of the allosterically activated ternary complex. The transient nature and usually slow millisecond time scale interconversion between these functional states hamper their experimental and computational characterization. Here, we combine extensive molecular dynamics simulations, enhanced sampling techniques, and dynamical networks to describe the allosteric activation of imidazole glycerol phosphate synthase (IGPS) from the substrate-free form to the active ternary complex. IGPS is a heterodimeric bienzyme complex whose HisH subunit is responsible for hydrolyzing glutamine and delivering ammonia for the cyclase activity in HisF. Despite significant advances in understanding the underlying allosteric mechanism, essential molecular details of the long-range millisecond allosteric activation of IGPS remain hidden. Without using a priori information of the active state, our simulations uncover how IGPS, with the allosteric effector bound in HisF, spontaneously captures glutamine in a catalytically inactive HisH conformation, subsequently attains a closed HisF:HisH interface, and finally forms the oxyanion hole in HisH for efficient glutamine hydrolysis. We show that the combined effector and substrate binding dramatically decreases the conformational barrier associated with oxyanion hole formation, in line with the experimentally observed 4500-fold activity increase in glutamine hydrolysis. The allosteric activation is controlled by correlated time-evolving dynamic networks connecting the effector and substrate binding sites. This computational strategy tailored to describe millisecond events can be used to rationalize the effect of mutations on the allosteric regulation and guide IGPS engineering efforts, The authors thank the Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707) and Spanish MINECO for projects PGC2018-102192-B-I00 (S.O), RTI2018-101032-J100 (F.F), and RYC2020-029552-I (F.F.). S.O. is grateful for the funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Program (ERC-2015-StG-679001) and the Human Frontier Science Program (HFSP) for Project Grant RGP0054/2020. F.F. thanks the Spanish Supercomputing Network (RES) for access to supercomputing resources (Project BCV-2021-1-0015). M.A.M.-S. was supported by the National Research Foundation of Korea (NRF) under the Brain Pool Program (NRF2021H1D3A2A02038434). Open Access funding provided thanks to the CRUE-CSIC agreement with ACS.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deciphering the Allosterically Driven Conformational Ensemble in Tryptophan Synthase Evolution

  • Maria-Solano, Miguel A.
  • Iglesias-Fernández, Javier
  • Osuna Oliveras, Sílvia
Multimeric enzyme complexes are ubiquitous in nature and catalyze a broad range of useful biological transformations. They are often characterized by a tight allosteric coupling between subunits, making them highly inefficient when isolated. A good example is Tryptophan synthase (TrpS), an allosteric heterodimeric enzyme in the form of an αββα complex that catalyzes the biosynthesis of L-tryptophan. In this study, we decipher the allosteric regulation existing in TrpS from Pyrococcus furiosus (PfTrpS), and how the allosteric conformational ensemble is recovered in laboratory-evolved stand-alone β-subunit variants. We find that recovering the conformational ensemble of a subdomain of TrpS affecting the relative stabilities of open, partially closed, and closed conformations is a prerequisite for enhancing the catalytic efficiency of the β-subunit in the absence of its binding partner. The distal mutations resuscitate the allosterically driven conformational regulation and alter the populations and rates of exchange between these multiple conformational states, which are essential for the multistep reaction pathway of the enzyme. Interestingly, these distal mutations can be a priori predicted by careful analysis of the conformational ensemble of the TrpS enzyme through computational methods. Our study provides the enzyme design field with a rational approach for evolving allosteric enzymes toward improved stand-alone function for biosynthetic applications, We thank the Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707) and Spanish MINECO for project PGC2018-102192-B-I00. We are grateful for the computer resources, technical expertise, and assistance provided by the Barcelona Supercomputing Center - Cen-tro Nacional de Supercomputación. M. A. M. S. was sup-ported by the Spanish MINECO for a PhD fellowship (BES-2015-074964), J. I. F. was supported by the European Community for Marie Curie fellowship (H2020-MSCA-IF-2016-753045). S.O. is grateful to the funding from the Eu-ropean Research Council (ERC) under the European Un-ion’s Horizon 2020 research and innovation program (ERC-2015-StG-679001)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Biocatalysis

  • Bell, Elizabeth L.
  • Finnigan, William
  • France, Scott P.
  • Green, Anthony P.
  • Hayes, Martin A.
  • Hepworth, Lorna J.
  • Lovelock, Sarah L.
  • Niikura, Haruka
  • Osuna Oliveras, Sílvia
  • Romero, Elvira
  • Ryan, Katherine S.
  • Turner, Nicholas J.
  • Flitsch, Sabine L.
Biocatalysis has become an important aspect of modern organic synthesis, both in academia and across the chemical and pharmaceutical industries. Its success has been largely due to a rapid expansion of the range of chemical reactions accessible, made possible by advanced tools for enzyme discovery coupled with high-throughput laboratory evolution techniques for biocatalyst optimization. A wide range of tailor-made enzymes with high efficiencies and selectivities can now be produced quickly and on a gram to kilogram scale, with dedicated databases and search tools aimed at making these biocatalysts accessible to a broader scientific community. This Primer discusses the current state-of-the-art methodology in the field, including route design, enzyme discovery, protein engineering and the implementation of biocatalysis in industry. We highlight recent advances, such as de novo design and directed evolution, and discuss parameters that make a good reproducible biocatalytic process for industry. The general concepts will be illustrated by recent examples of applications in academia and industry, including the development of multistep enzyme cascades, The authors are grateful for funding from the European Research Council (ERC) (S.L.F., 788231; A.P.G., 757991; S.O., 679001; N.J.T., 742987), the Engineering and Physical Sciences Research Council (EPSRC) (S.L.F. and N.J.T., EP/S005226/1), the Biotechnology and Biological Sciences Research Council (BBSRC) (S.L.F. and N.J.T., BB/M027791/1, BB/M028836/1; A.P.G., BB/M027023/1), the Spanish Ministry of Economy and Competitiveness (MINECO) (S.O., PGC2018-102192-B-I00), Generalitat de Catalunya (S.O., SGR 2017 1707) and the University of Manchester (Presidential Fellowship to S.L.L.)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The challenge of predicting distal active site mutations in computational enzyme design

  • Osuna Oliveras, Sílvia
Many computational enzyme design approaches have been developed in recent years that focus on a reduced set of key enzymatic features. Initial protocols mostly focused on the chemical steps(s) through transition state stabilization, whereas most recent approaches exploit the enzyme conformational dynamics often crucial for substrate binding, product release, and allosteric regulation. The detailed evaluation of the conformational landscape of many laboratory-evolved enzymes has revealed dramatic changes on the relative stabilities of the conformational states after mutation, favoring those conformational states key for the novel functionality. Of note is that these mutations are often located all around the enzyme structure, which contrasts with most of the computational design strategies that reduce the problem into active site alterations. Recent computational strategies have been developed that consider enzyme design as a population shift problem, that is, redistribution of the relative stabilities of the conformational states induced by mutations. These strategies focus on reconstructing the conformational landscape of the enzyme, applying correlation-based tools to elucidate the underlying allosteric network of interactions and identify potential mutation hotspots located at the active site, but most importantly at distal positions for the first time, I thank the Generalitat de Catalunya for the emerging group CompBioLab (2017 SGR-1707), Spanish MINECO for project PGC2018-102192-B-I00, and the funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC-2015-StG-679001)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Estimating conformational heterogeneity of tryptophan synthase with a template-based Alphafold2 approach

  • Casadevall Franco, Guillem
  • Duran i Rebenaque, Cristina
  • Estévez Gay, Miquel
  • Osuna Oliveras, Sílvia
The three-dimensional structure of the enzymes provides very relevant information on the arrangement of the catalytic machinery and structural elements gating the active site pocket. The recent success of the neural network Alphafold2 in predicting the folded structure of proteins from the primary sequence with high levels of accuracy has revolutionized the protein design field. However, the application of Alphafold2 for understanding and engineering function directly from the obtained single static picture is not straightforward. Indeed, understanding enzymatic function requires the exploration of the ensemble of thermally accessible conformations that enzymes adopt in solution. In the present study, we evaluate the potential of Alphafold2 in assessing the effect of the mutations on the conformational landscape of the beta subunit of tryptophan synthase (TrpB). Specifically, we develop a template-based Alphafold2 approach for estimating the conformational heterogeneity of several TrpB enzymes, which is needed for enhanced stand-alone activity. Our results show the potential of Alphafold2, especially if combined with molecular dynamics simulations, for elucidating the changes induced by mutation in the conformational landscapes at a rather reduced computational cost, thus revealing its plausible application in computational enzyme design, H2020 European Research Council. Grant Number: ERC-2015-StG-679001 Human Frontier Science Program. Grant Number: RGP0054/2020 Ministerio de Ciencia e Innovación. Grant Number: PGC2018-102192-B-I00, Open Access funding provided thanks to the CRUE-CSIC agreement with Wiley
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain, A New Indication for Soluble Epoxide Hydrolase Inhibitors

  • Codony, Sandra|||0000-0003-0539-673X
  • Entrena, José M.|||0000-0002-4319-746X
  • Calvó-Tusell, Carla|||0000-0003-2681-8460
  • Jora, Beatrice
  • González-Cano, Rafael|||0000-0002-9657-4521
  • Osuna, Sílvia|||0000-0003-3657-6469
  • Corpas, Rubén|||0000-0002-7051-1493
  • Morisseau, Christophe
  • Pérez, Belén|||0000-0001-5801-1704
  • Barniol-Xicota, Marta|||0000-0001-7957-2199
  • Griñán-Ferré, Christian|||0000-0002-5424-9130
  • Pérez, Concepción
  • Rodríguez-Franco, María Isabel|||0000-0002-6500-792X
  • Martínez, Antón L.|||0000-0002-1595-3459
  • Loza, María Isabel|||0000-0003-4730-0863
  • Pallàs, Mercè|||0000-0003-3095-4254
  • Verhelst, Steven H. L.|||0000-0002-7400-1319
  • Sanfeliu i Pujol, Coral|||0000-0002-9004-1206
  • Feixas, Ferran|||0000-0001-5147-0000
  • Hammock, Bruce D.|||0000-0003-1408-8317
  • Brea, José|||0000-0002-5523-1979
  • Cobos, Enrique J.
  • Vázquez, Santiago|||0000-0002-9296-6026
The soluble epoxide hydrolase (sEH) has been suggested as a pharmacological target for the treatment of several diseases, including pain-related disorders. Herein, we report further medicinal chemistry around new benzohomoadamantane-based sEH inhibitors (sEHI) in order to improve the drug metabolism and pharmacokinetics properties of a previous hit. After an extensive in vitro screening cascade, molecular modeling, and in vivo pharmacokinetics studies, two candidates were evaluated in vivo in a murine model of capsaicin-induced allodynia. The two compounds showed an anti-allodynic effect in a dose-dependent manner. Moreover, the most potent compound presented robust analgesic efficacy in the cyclophosphamide-induced murine model of cystitis, a well-established model of visceral pain. Overall, these results suggest painful bladder syndrome as a new possible indication for sEHI, opening a new range of applications for them in the visceral pain field.